Search results for " Type II"

showing 10 items of 542 documents

Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only*

2011

Background: Procollagen C-proteinase enhancer-1 (PCPE-1) is an extracellular glycoprotein that increases activity of certain zinc metalloproteinases involved in tissue development and repair. Results: PCPE-1 binds uniquely to the C-propeptide region of the procollagen molecule. Conclusion: PCPE-1 enhances proteolysis by binding solely to the procollagen C-propeptides. Significance: These data may lead to future applications in the development of antifibrotic therapies.

animal structuresGlycosylationBiologyBiochemistryBone morphogenetic protein 1Protein Structure SecondaryBone Morphogenetic Protein 103 medical and health scienceschemistry.chemical_compoundMetalloprotease0302 clinical medicineHumansBinding siteEnhancerMolecular Biology030304 developmental biologyCell Line TransformedGlycoproteinschemistry.chemical_classification0303 health sciencesMetalloproteinaseExtracellular Matrix ProteinsBinding Sitesintegumentary systemCell BiologyEnzymatic ProcessingFibrosisExtracellular MatrixProcollagen peptidaseCollagen Type IIIchemistryBiochemistry030220 oncology & carcinogenesisembryonic structuresEnzymologyCollagenGlycoproteinProtein Processing Post-TranslationalTriple helixThe Journal of Biological Chemistry
researchProduct

Lactobacillus tucceti sp. nov., a new lactic acid bacterium isolated from sausage

2006

Abstract Following the application of several molecular techniques strain R 19c, isolated from sausage by Reuter in 1970 and deposited at the DSMZ as Lactobacillus sp., has been identified as pertaining to a new species. It showed singular ISR- Dde I and ISR- Hae III profiles that allowed its differentiation from 68 lactic acid bacteria reference strains analyzed. Phylogenetic analysis based on 16S rRNA gene sequences places this strain in the genus Lactobacillus within the Lactobacillus alimentarius group. Species L. versmoldensis is the closest phylogenetic neighbor with 96.3% sequence similarity. DNA–DNA hybridization experiments confirmed the independent status at species level of this …

biologyRhamnoseNucleic Acid Hybridizationfood and beveragesbiology.organism_classification16S ribosomal RNADNA RibosomalPolymerase Chain ReactionApplied Microbiology and BiotechnologyMicrobiologyLactic acidMicrobiologyMeat ProductsLactobacilluschemistry.chemical_compoundPhenotypechemistryLactobacillusPeptidoglycanDeoxyribonucleases Type II Site-SpecificMelibioseRibosomal DNAPhylogenyEcology Evolution Behavior and SystematicsBacteriaSystematic and Applied Microbiology
researchProduct

Plant iNOS: conquest of the Holy Grail

2003

In animals, nitric oxide (NO) is produced by a family of enzymes named nitric oxide synthases (NOSs). Although no NOS-like gene has been found in the Arabidopsis thaliana genome, biochemical studies have suggested that a NOS-like protein is likely to be activated in plants resisting pathogens. This protein has been recently identified as a variant P protein of glycine decarboxylase. This discovery means that studies of nitric oxide signalling functions in plants are now entering a new phase.

chemistry.chemical_classificationbiologyArabidopsisNitric Oxide Synthase Type IIfood and beveragesPlant Sciencebiology.organism_classificationModels BiologicalNitric oxideNitric oxide synthasechemistry.chemical_compoundEnzymechemistryBiochemistryArabidopsisTobaccoGlycinebiology.proteinAnimalsArabidopsis thalianaNitric Oxide SynthaseSignal transductionGeneGenome PlantTrends in Plant Science
researchProduct

WRN protects against topo I but not topo II inhibitors by preventing DNA break formation

2008

The Werner syndrome helicase/3′-exonuclease (WRN) is a major component of the DNA repair and replication machinery. To analyze whether WRN is involved in the repair of topoisomerase-induced DNA damage we utilized U2-OS cells, in which WRN is stably down-regulated (wrn-kd), and the corresponding wild-type cells (wrn-wt). We show that cells not expressing WRN are hypersensitive to the toxic effect of the topoisomerase I inhibitor topotecan, but not to the topoisomerase II inhibitor etoposide. This was shown by mass survival assays, colony formation and induction of apoptosis. Upon topotecan treatment WRN deficient cells showed enhanced DNA replication inhibition and S-phase arrest, whereas af…

congenital hereditary and neonatal diseases and abnormalitiesWerner Syndrome HelicaseDNA RepairCell SurvivalDNA damageDNA repairBlotting WesternApoptosisBone NeoplasmsBiologyTopoisomerase-I InhibitorBiochemistryArticleWerner Syndrome HelicaseColony-Forming Units AssayHistonesTumor Cells CulturedmedicineHumansTopoisomerase II InhibitorsEnzyme InhibitorsRNA Small InterferingeducationMolecular BiologyEtoposideOsteosarcomaeducation.field_of_studyRecQ HelicasesTopoisomeraseCell CycleDNA Breaksnutritional and metabolic diseasesCell BiologyAntineoplastic Agents PhytogenicMolecular biologyDNA Topoisomerases Type IIExodeoxyribonucleasesBromodeoxyuridineDNA Topoisomerases Type IDNA Replication InhibitionCancer researchbiology.proteinTopoisomerase I InhibitorsTopoisomerase-II InhibitorTopotecanCamptothecinmedicine.drugDNA Repair
researchProduct

219 Incidence Testing of Hunter Syndrome in A Population at Risk - First Results of A Binational Screening Programme

2012

Background Hunter syndrome (Mucopolysaccharidosis type II; X-linked inheritance; prevalence rate in Europe approximately 1:77000 male newborns) is a rare, progressive, multisystemic disease, caused by deficiency of the lysosomal enzyme Iduronate-2-sulfatase. Due to the very heterogeneous phenotype Hunter syndrome is often not diagnosed before pre-school age. This is unfortunate, because patients would significantly benefit from the earliest possible start of treatment containing enzyme replacement therapy. Early screening methods are possible, but due to the rarity of this disease they are too expensive to be performed in all newborns. An at-risk patient population screening provides opport…

education.field_of_studyPediatricsmedicine.medical_specialtybusiness.industryIncidence (epidemiology)PopulationPrevalenceHunter syndromeEnzyme replacement therapymedicine.diseaseUmbilical herniaPediatrics Perinatology and Child Healthmedicinemedia_common.cataloged_instanceEuropean unionMucopolysaccharidosis type IIbusinesseducationmedia_commonArchives of Disease in Childhood
researchProduct

Learning Curve in Surgical Treatment of Odontoid Fixation for a Series of Type II C2 Fractures

2019

The craniovertebral junction (CVJ) is a complex anatomical area upon which most of the motion of the upper cervical spine depends [1]. Because of its unique range of motion, the CVJ is subject to several types of traumatic injury; it has been shown that odontoid fractures are the most common ones in the general population and are the most common isolated spinal fractures [2]. Accounting for up to 18% of all cervical fractures, odontoid fractures are the most common ones in elderly patients [3], in whom they account for up to 60% of spinal cord injuries [4].

education.field_of_studymedicine.medical_specialtySettore MED/27 - Neurochirurgiabusiness.industryPopulationSpinal cordCervical spine030218 nuclear medicine & medical imagingSurgery03 medical and health sciencesFixation (surgical)0302 clinical medicinemedicine.anatomical_structureTraumatic injurymedicineC1–C2 articular screw Learning Curve C1–C2 instability Odontoid screw Type II odontoid fracture Aged Fracture Fixation Internal Bone Screws Odontoid Process Spinal Cord Injuries Treatment Outcome Spinal Fractures Humans Spinal FusionbusinessSurgical treatmentRange of motioneducation030217 neurology & neurosurgery
researchProduct

Artificial cartilage bio-matrix formed of hyaluronic acid and Mg2+-polyphosphate.

2016

Here we show that inorganic polyphosphate (polyP), a polyanionic metabolic regulator consisting of multiple phosphate residues linked by energy-rich phosphoanhydride bonds, is present in the synovial fluid. In a biomimetic approach, to enhance cartilage synthesis and regeneration, we prepared amorphous polyP microparticles with Mg2+ as counterions. The particles were characterised by X-ray diffraction (XRD), energy-dispersive X-ray (EDX) and Fourier transformed infrared spectroscopic (FTIR) analyses. Similar particles were obtained after addition of Mg2+ ions to a solution containing hyaluronic acid, as a major component of the synovial fluid, and soluble Na-polyP. The viscous paste-like ma…

magnesium polyphosphatelcsh:Diseases of the musculoskeletal systemlcsh:Surgeryregenerative medicine02 engineering and technologyCartilage metabolism01 natural sciencesChondrocyteExtracellular matrixchemistry.chemical_compoundCollagen Type IIIChondrocytesX-Ray DiffractionPolyphosphatesHyaluronic acidSpectroscopy Fourier Transform InfraredSynovial FluidmedicineCell AdhesionSynovial fluidHumansMagnesiumRNA MessengerHyaluronic Acidmicroparticles010405 organic chemistryCartilagePolyphosphateSpectrometry X-Ray EmissionSOX9 Transcription Factorlcsh:RD1-811021001 nanoscience & nanotechnology0104 chemical sciencesExtracellular MatrixUp-Regulationosteoarthritismedicine.anatomical_structureCartilageCollagen Type IIIchemistrytissue engineeringBiophysicsMicroscopy Electron Scanninglcsh:RC925-9350210 nano-technologyBiomedical engineering
researchProduct

Anti-inflammatory activity of flavonoids from Cayaponia tayuya roots.

2008

Taiuiá or tayuya (Cayaponia tayuya, Cucurbitaceae) is a climbing, lignified plant with a large swollen root that has traditionally been used as an anti-inflammatory and anti-rheumatic agent in the folk medicine of Brazil, Peru, and Colombia.We have assayed the pharmacological properties of a flavonoid fraction obtained from the butanol extract of Cayaponia tayuya roots using two models of topical mouse ear oedema, paying special attention to its influence on the induction on pro-inflammatory enzymes and peptidic mediators.The in vivo experiments involved both the acute oedema induced by a single application of TPA and the subchronic inflammation brought on by repeated applications of TPA. T…

medicine.drug_classFlavonoidIsovitexinAnti-Inflammatory AgentsNitric Oxide Synthase Type IIPharmacologyPharmacognosyColombiaPlant RootsAnti-inflammatoryCell Linechemistry.chemical_compoundMiceWestern blotIn vivoDrug DiscoveryPerumedicineAnimalsPharmacologychemistry.chemical_classificationFlavonoidsInflammationbiologymedicine.diagnostic_testbusiness.industryPlant ExtractsMacrophagesbiology.organism_classificationCayaponia tayuyaCucurbitaceaeDisease Models AnimalchemistryBiochemistryCyclooxygenase 2biology.proteinFemaleCyclooxygenaseMedicine TraditionalbusinessBrazilJournal of ethnopharmacology
researchProduct

Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes.

2009

Inflammation has been implicated in neurodegenerative disorders such as Alzheimer's disease (AD). The main inflammatory players in AD are the glial cells which initiate the inflammatory response. One of the earliest neuropathological changes in AD is the accumulation of astrocytes at sites of A beta deposition. It is desirable to find methods of tipping the balance towards anti-inflammatory state. Estrogenic compounds have shown anti-inflammatory and also antioxidant activity. Astrocytes were pretreated with 17-beta estradiol or with genistein, and 48 h later treated with 5 microM amyloid beta (A beta) for 24 h. We found that A beta induces inflammatory mediators, such as cyclooxygenase 2 (…

medicine.medical_specialtyAmyloid betaInterleukin-1betaGenisteinPeroxisome proliferator-activated receptorNitric Oxide Synthase Type IIInflammationEnzyme-Linked Immunosorbent Assaychemistry.chemical_compoundInternal medicinemedicineAnimalsDrug InteractionsMolecular BiologyProtein Kinase InhibitorsCells Culturedchemistry.chemical_classificationCerebral CortexAmyloid beta-PeptidesbiologyDose-Response Relationship DrugEstradiolTumor Necrosis Factor-alphaGeneral NeuroscienceInterleukinEstrogensGenisteinPeptide FragmentsRatsPPAR gammaEndocrinologymedicine.anatomical_structurechemistryGene Expression RegulationCyclooxygenase 2Astrocytesbiology.proteinNeurogliaTumor necrosis factor alphaNeurology (clinical)medicine.symptomDevelopmental BiologyAstrocyteBrain research
researchProduct

Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex

2004

medicine.medical_specialtyAngiotensin receptorAngioedemaC1 inhibitor deficiencybusiness.industryFemale sexGeneral Medicinemedicine.diseaseEndocrinologyInternal medicineHereditary angioedemamedicineHereditary Angioedema Type IIImedicine.symptombusinessThe American Journal of Medicine
researchProduct